Enter your terms above and click the 'Search' button.

Showing articles 0 to 6 of 6 Filter Applied: interferon beta 1-a (Click to remove) Superior MRI Outcomes with Alemtuzumab Compared with Subcutaneous Interferon �-1a in MS Neurol 87:1464-1472, Arnold, D.L.,et al, 2016 Daclizumab HYP versus Interferon Beta-1a in Relapsing Multiple Sclerosis NEJM 373:1418-1428, Kappos, L.,et al, 2015 Multiple Sclerosis Therapeutics: Unexpected Outcomes Clouding Undisputed Successes Neurol 72:1008-1015, Wiendl,H. &Hohlfeld,R., 2009 Alemtuzumab vs. Interferon Beta-1a in Early Multiple Sclerosis NEJM 359:1786-1801,1838, The CAMMS223 Trial Investigators, 2008 Quantifying the Risks and Benefits of Natalizumab in Relapsing Multiple Sclerosis Neurol 68:1524-1528, Dorsey,E.R.,et al, 2007 Natalizumab Plus Interferon Beta -1a for Relapsing Multiple Sclerosis NEJM 354:911-923,965, Rudick,R.A.,et al, 2006 Showing articles 0 to 6 of 6